Social Media Buzz 4/27/12

Vernalis Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier

CytRx CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer

Cryolife CryoLife Reports Record Quarterly Revenues in First Quarter of 2012

Repligen Repligen hit by FDA setback, shares plummet 41 percent